Trial Condition(s):
Angeliq low/low: MD PK
Please see attached Study Results Summary below
No Inclusion Criteria Available
No Exclusion Criteria Available
Locations | Status | ||
---|---|---|---|
Locations Bayer Schering Pharma AG Berlin, Germany, 13353 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |